Orexin Receptor Antagonist [EPC]

Orexin Receptor Antagonist [EPC] was reported 18631 times

Drugs of the Orexin Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 BILE ACIDS 8 0.8889
1 HYPOKINETIC DYSARTHRIA 23 0.7667
2 TARDIVE SEIZURE 8 0.5714
3 CLENCHED HAND 8 0.4444
4 SMEAR CERVIX 8 0.3810
5 TURBINOPLASTY 8 0.2963
6 BIOPSY TONGUE 8 0.2667
7 SLEEP PARALYSIS 385 0.2621
8 SECONDARY TIC 8 0.1951
9 ORAL HAIRY LEUKOPLAKIA 8 0.1600
10 BIOPSY CERVIX 8 0.1538
11 FEAR OF WEIGHT GAIN 8 0.1379
12 CLAUDICATION OF JAW MUSCLES 8 0.1333
13 NEONATAL HEPATOMEGALY 7 0.1250
14 SOMATIC SYMPTOM DISORDER OF PREGNANCY 8 0.1143
15 TONGUE ROUGH 8 0.0941
16 NEONATAL HYPOCALCAEMIA 7 0.0933
17 LABELLED DRUG-FOOD INTERACTION ISSUE 11 0.0647
18 LEUKOPLAKIA 15 0.0612
19 GLOSSOPTOSIS 10 0.0457
20 HYPNAGOGIC HALLUCINATION 13 0.0426
21 JAW CLICKING 8 0.0376
22 CATAPLEXY 51 0.0360
23 ABNORMAL SLEEP-RELATED EVENT 44 0.0333
24 HANGOVER 114 0.0324
25 NIGHTMARE 1101 0.0318
26 TONGUE GEOGRAPHIC 8 0.0316
27 OROMANDIBULAR DYSTONIA 23 0.0316
28 NEONATAL BEHAVIOURAL SYNDROME 9 0.0294
29 PRODUCT BLISTER PACKAGING ISSUE 30 0.0288
30 SOMNAMBULISM 185 0.0282
31 ABNORMAL DREAMS 778 0.0281
32 DYSPRAXIA 15 0.0266
33 CHANGE IN SUSTAINED ATTENTION 8 0.0266
34 SLEEP-RELATED EATING DISORDER 24 0.0256
35 FOETAL MACROSOMIA 7 0.0252
36 PARASOMNIA 17 0.0236
37 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 10 0.0234
38 HYPERVIGILANCE 22 0.0228
39 NASAL SEPTAL OPERATION 8 0.0221
40 LID SULCUS DEEPENED 8 0.0214
41 CENTRAL HYPOTHYROIDISM 7 0.0211
42 LUMBAR PUNCTURE 8 0.0211
43 SLEEP TERROR 85 0.0202
44 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 10 0.0200
45 TRICHOGLOSSIA 8 0.0195
46 ANTEROGRADE AMNESIA 11 0.0184
47 OESOPHAGEAL DILATATION 8 0.0181
48 THERAPEUTIC RESPONSE INCREASED 16 0.0170
49 PLICATED TONGUE 8 0.0168
50 AUTOSCOPY 9 0.0167
51 TONGUE ERUPTION 8 0.0161
52 PRODUCT PACKAGING DIFFICULT TO OPEN 42 0.0161
53 WATER INTOXICATION 8 0.0158
54 LEUKOPLAKIA ORAL 8 0.0156
55 PHYSICAL DECONDITIONING 39 0.0151
56 DRUG EFFECT PROLONGED 8 0.0145
57 MIDDLE INSOMNIA 261 0.0140
58 SLEEP TALKING 23 0.0135
59 AMBLYOPIA 8 0.0135
60 HEAT ILLNESS 9 0.0133
61 POOR QUALITY SLEEP 286 0.0133
62 TERMINAL INSOMNIA 23 0.0130
63 MOANING 14 0.0123
64 PLEUROTHOTONUS 11 0.0122
65 MENTAL DISABILITY 7 0.0121
66 INITIAL INSOMNIA 117 0.0114
67 THERAPEUTIC PRODUCT EFFECT DELAYED 52 0.0114
68 CONTRAINDICATED PRODUCT PRESCRIBED 19 0.0113
69 LIP EROSION 8 0.0110
70 CHOLANGITIS ACUTE 8 0.0106
71 SEDATION COMPLICATION 27 0.0106
72 TONGUE PRURITUS 9 0.0105
73 THERAPEUTIC PRODUCT EFFECT INCREASED 12 0.0103
74 MARASMUS 15 0.0099
75 BRAIN CONTUSION 7 0.0096
76 NEONATAL RESPIRATORY DISTRESS 9 0.0095
77 IMMUNE-MEDIATED HEPATIC DISORDER 18 0.0092
78 CLAUSTROPHOBIA 10 0.0092
79 SPUTUM RETENTION 9 0.0091
80 LABELLED DRUG-DRUG INTERACTION ISSUE 13 0.0090
81 DRUG EFFECT VARIABLE 10 0.0088
82 CIRCADIAN RHYTHM SLEEP DISORDER 7 0.0084
83 TACHYPHRENIA 29 0.0084
84 PRODUCT AVAILABILITY ISSUE 190 0.0083
85 NARCOLEPSY 15 0.0079
86 DRUG EFFECT DELAYED 36 0.0079
87 THERAPEUTIC PRODUCT EFFECT VARIABLE 30 0.0077
88 INTRUSIVE THOUGHTS 9 0.0076
89 ABULIA 7 0.0076
90 UPPER RESPIRATORY TRACT INFLAMMATION 9 0.0075
91 VULVOVAGINAL CANDIDIASIS 10 0.0074
92 KLEBSIELLA BACTERAEMIA 7 0.0074
93 INFECTIOUS PLEURAL EFFUSION 11 0.0072
94 VANISHING BILE DUCT SYNDROME 8 0.0072
95 ALTERED STATE OF CONSCIOUSNESS 155 0.0071
96 GLOSSITIS 24 0.0068
97 HALLUCINATION 505 0.0067
98 CARPAL TUNNEL DECOMPRESSION 7 0.0066
99 HYDROCELE 7 0.0066
100 SUDDEN ONSET OF SLEEP 9 0.0065
101 CONCOMITANT DISEASE AGGRAVATED 40 0.0065
102 FEMORAL NECK FRACTURE 33 0.0064
103 DELIRIUM 219 0.0063
104 PNEUMONIA KLEBSIELLA 11 0.0060
105 TONGUE DRY 8 0.0059
106 POLYCYSTIC OVARIES 9 0.0058
107 AKINESIA 12 0.0058
108 HYPOTONIA NEONATAL 9 0.0058
109 ORAL MUCOSA EROSION 7 0.0057
110 DEPRESSIVE SYMPTOM 20 0.0057
111 RADIATION PNEUMONITIS 12 0.0056
112 STUPOR 18 0.0056
113 ENURESIS 22 0.0054
114 THERAPEUTIC RESPONSE DELAYED 15 0.0054
115 ORAL MUCOSAL EXFOLIATION 8 0.0053
116 SOMNOLENCE 1064 0.0053
117 PARALYSIS 74 0.0052
118 CARDIAC FAILURE CHRONIC 22 0.0052
119 AGORAPHOBIA 7 0.0051
120 SCREAMING 32 0.0050
121 IMMUNE-MEDIATED MYOCARDITIS 8 0.0050
122 SLEEP DEFICIT 10 0.0047
123 MYASTHENIA GRAVIS CRISIS 7 0.0047
124 ENTERITIS INFECTIOUS 8 0.0047
125 SUICIDE ATTEMPT 284 0.0047
126 TONGUE COATED 8 0.0046
127 HEPATIC FUNCTION ABNORMAL 171 0.0046
128 HAEMORRHAGE SUBCUTANEOUS 16 0.0045
129 HALLUCINATION, AUDITORY 70 0.0044
130 NEUROLEPTIC MALIGNANT SYNDROME 52 0.0044
131 PNEUMONIA ASPIRATION 109 0.0044
132 PARADOXICAL DRUG REACTION 16 0.0043
133 PSYCHIATRIC SYMPTOM 31 0.0042
134 SUICIDAL IDEATION 384 0.0042
135 DRUG EFFECT INCOMPLETE 152 0.0042
136 INSOMNIA 1104 0.0041
137 PYELONEPHRITIS ACUTE 8 0.0041
138 DIPLEGIA 8 0.0040
139 FEELING DRUNK 30 0.0040
140 HYPOPITUITARISM 7 0.0040
141 PARKINSONISM 39 0.0040
142 RESTLESSNESS 146 0.0040
143 CHRONIC GASTRITIS 9 0.0040
144 SMALL INTESTINAL HAEMORRHAGE 8 0.0040
145 PNEUMONIA BACTERIAL 36 0.0039
146 RESTLESS LEGS SYNDROME 71 0.0039
147 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 40 0.0039
148 HYPERURICAEMIA 16 0.0039
149 FEELING JITTERY 74 0.0039
150 CONCUSSION 30 0.0039
151 IMMUNE-MEDIATED LUNG DISEASE 7 0.0038
152 POISONING DELIBERATE 36 0.0038
153 CARDIAC FAILURE ACUTE 25 0.0037
154 PANIC REACTION 27 0.0037
155 INTENTIONAL OVERDOSE 239 0.0037
156 DRUG ERUPTION 66 0.0037
157 HEPATITIS FULMINANT 11 0.0037
158 INTENTIONAL UNDERDOSE 27 0.0037
159 ASPHYXIA 30 0.0037
160 PNEUMONIA CYTOMEGALOVIRAL 7 0.0036
161 ANXIETY DISORDER 12 0.0036
162 BRAIN FOG 56 0.0036
163 COMPRESSION FRACTURE 19 0.0035
164 NOCTURIA 43 0.0035
165 INABILITY TO AFFORD MEDICATION 35 0.0035
166 CANCER PAIN 9 0.0035
167 HYPERPHAGIA 14 0.0035
168 MENOPAUSE 9 0.0035
169 LOSS OF THERAPEUTIC RESPONSE 11 0.0034
170 SNORING 13 0.0034
171 SEDATION 89 0.0034
172 CHOLANGITIS 21 0.0034
173 SLEEP DISORDER 239 0.0034
174 BRUXISM 18 0.0033
175 INTERSTITIAL LUNG DISEASE 159 0.0033
176 CEREBRAL INFARCTION 79 0.0032
177 ERYTHEMA MULTIFORME 30 0.0032
178 GLUCOSE TOLERANCE IMPAIRED 19 0.0032
179 DISSOCIATION 24 0.0031
180 HYPERTONIC BLADDER 9 0.0031
181 GASTROINTESTINAL HYPOMOTILITY 7 0.0031
182 PANIC DISORDER 12 0.0031
183 DEPRESSED LEVEL OF CONSCIOUSNESS 122 0.0031
184 LIVER ABSCESS 10 0.0031
185 PEMPHIGOID 23 0.0030
186 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 10 0.0030
187 BLOOD PROLACTIN INCREASED 14 0.0030
188 DYSLIPIDAEMIA 15 0.0030
189 THINKING ABNORMAL 55 0.0029
190 DRUG INEFFECTIVE 3857 0.0029
191 AGITATION 213 0.0029
192 ENERGY INCREASED 17 0.0029
193 ELECTRIC SHOCK SENSATION 8 0.0029
194 MANIA 47 0.0029
195 SLUGGISHNESS 29 0.0028
196 HYPERNATRAEMIA 14 0.0028
197 TUMOUR HAEMORRHAGE 8 0.0028
198 SCHIZOPHRENIA 34 0.0028
199 ENTEROCOLITIS 16 0.0028
200 HYPERVENTILATION 16 0.0028
201 BIPOLAR DISORDER 30 0.0028
202 HALLUCINATION, VISUAL 58 0.0027
203 GASTROINTESTINAL NECROSIS 8 0.0027
204 HEAD DISCOMFORT 48 0.0027
205 FEELING ABNORMAL 648 0.0027
206 ILEUS PARALYTIC 12 0.0027
207 HICCUPS 22 0.0027
208 HYPERSOMNIA 76 0.0026
209 ATTENTION DEFICIT HYPERACTIVITY DISORDER 11 0.0026
210 PSYCHOMOTOR HYPERACTIVITY 43 0.0026
211 FORMICATION 18 0.0026
212 DIZZINESS POSTURAL 25 0.0026
213 URINARY RETENTION 86 0.0026
214 SUSPECTED SUICIDE 12 0.0026
215 PULMONARY TOXICITY 18 0.0025
216 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 15 0.0025
217 DRUG SCREEN FALSE POSITIVE 7 0.0025
218 PRODUCT SUPPLY ISSUE 18 0.0025
219 CYTOKINE RELEASE SYNDROME 50 0.0025
220 AKATHISIA 34 0.0025
221 MYASTHENIA GRAVIS 20 0.0025
222 POOR QUALITY PRODUCT ADMINISTERED 26 0.0025
223 IMMUNE-MEDIATED ENTEROCOLITIS 9 0.0024
224 LISTLESS 8 0.0024
225 NEAR DEATH EXPERIENCE 8 0.0024
226 NO ADVERSE EVENT 439 0.0024
227 AORTIC DISSECTION 10 0.0024
228 PRESCRIBED UNDERDOSE 48 0.0024
229 SUICIDAL BEHAVIOUR 10 0.0024
230 IMPAIRED DRIVING ABILITY 27 0.0024
231 SLEEP APNOEA SYNDROME 45 0.0024
232 FRUSTRATION TOLERANCE DECREASED 19 0.0023
233 PRESCRIBED OVERDOSE 45 0.0023
234 TRISMUS 12 0.0023
235 INCOHERENT 15 0.0023
236 ADVERSE EVENT 213 0.0023
237 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 164 0.0023
238 TENSION 14 0.0023
239 SPINAL COMPRESSION FRACTURE 19 0.0023
240 ABNORMAL BEHAVIOUR 91 0.0023
241 TONGUE DISCOLOURATION 10 0.0023
242 ASPIRATION 25 0.0023
243 PRE-EXISTING CONDITION IMPROVED 14 0.0022
244 MOVEMENT DISORDER 72 0.0022
245 DRUG EFFECT LESS THAN EXPECTED 33 0.0022
246 ADRENAL INSUFFICIENCY 27 0.0022
247 PERIPHERAL ISCHAEMIA 9 0.0022
248 PNEUMONIA VIRAL 7 0.0022
249 FEAR 59 0.0022
250 HYPOMANIA 8 0.0022
251 NIGHT SWEATS 70 0.0022
252 HALLUCINATIONS, MIXED 9 0.0021
253 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
254 DELUSION 33 0.0021
255 DRUG LEVEL INCREASED 35 0.0021
256 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 13 0.0021
257 PRE-ECLAMPSIA 10 0.0021
258 NON-SMALL CELL LUNG CANCER 10 0.0021
259 GINGIVAL DISORDER 8 0.0021
260 SUDDEN DEATH 22 0.0021
261 PYELONEPHRITIS 18 0.0021
262 DYSKINESIA 84 0.0021
263 HEPATIC CYST 7 0.0021
264 PHOTOPSIA 13 0.0021
265 APNOEA 16 0.0021
266 THERAPEUTIC PRODUCT EFFECT DECREASED 92 0.0021
267 INCORRECT DOSAGE ADMINISTERED 10 0.0020
268 NEPHROTIC SYNDROME 14 0.0020
269 UNDERDOSE 148 0.0020
270 PRODUCT PRESCRIBING ISSUE 44 0.0020
271 DYSARTHRIA 76 0.0020
272 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 68 0.0020
273 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
274 OESOPHAGEAL CANDIDIASIS 8 0.0020
275 PRODUCT PACKAGING ISSUE 19 0.0020
276 LIVER DISORDER 88 0.0020
277 IMPAIRED GASTRIC EMPTYING 27 0.0020
278 DRUG TOLERANCE 10 0.0020
279 VITAMIN B12 DEFICIENCY 8 0.0020
280 HAEMOGLOBIN INCREASED 9 0.0020
281 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 12 0.0020
282 CORONAVIRUS INFECTION 13 0.0020
283 ESCHERICHIA INFECTION 16 0.0019
284 FEEDING DISORDER 39 0.0019
285 PANIC ATTACK 70 0.0019
286 DISSEMINATED INTRAVASCULAR COAGULATION 27 0.0019
287 MENTAL IMPAIRMENT 46 0.0019
288 THERAPY NON-RESPONDER 84 0.0019
289 HEAD INJURY 59 0.0019
290 BRADYKINESIA 11 0.0019
291 CHEILITIS 10 0.0018
292 CONJUNCTIVAL HAEMORRHAGE 7 0.0018
293 DEMENTIA 51 0.0018
294 SUBDURAL HAEMATOMA 26 0.0018
295 INTESTINAL ISCHAEMIA 10 0.0018
296 IRRITABILITY 109 0.0018
297 HEMIPLEGIA 15 0.0018
298 RESPIRATORY DEPRESSION 22 0.0018
299 POST-TRAUMATIC STRESS DISORDER 12 0.0018
300 PALPITATIONS 209 0.0018
301 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
302 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
303 DYSPHORIA 9 0.0018
304 POLYDIPSIA 7 0.0018
305 CHOLECYSTITIS ACUTE 10 0.0018
306 RENAL IMPAIRMENT 146 0.0017
307 EATING DISORDER 37 0.0017
308 NEPHROGENIC ANAEMIA 8 0.0017
309 ANGER 58 0.0017
310 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 7 0.0017
311 DRY MOUTH 139 0.0017
312 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 347 0.0017
313 RIGHT VENTRICULAR FAILURE 12 0.0017
314 COVID-19 PNEUMONIA 20 0.0017
315 DRUG-INDUCED LIVER INJURY 53 0.0017
316 DISTURBANCE IN ATTENTION 91 0.0017
317 PLEURISY 10 0.0017
318 GASTROINTESTINAL PERFORATION 7 0.0017
319 HYPOALBUMINAEMIA 13 0.0017
320 ORAL CANDIDIASIS 22 0.0017
321 AMNESIA 108 0.0017
322 EUPHORIC MOOD 17 0.0017
323 HUMERUS FRACTURE 8 0.0017
324 RHABDOMYOLYSIS 69 0.0017
325 INFUSION SITE PAIN 21 0.0016
326 ON AND OFF PHENOMENON 9 0.0016
327 HEART RATE ABNORMAL 9 0.0016
328 DIVERTICULUM INTESTINAL 7 0.0016
329 HYPERAMMONAEMIA 8 0.0016
330 DECUBITUS ULCER 13 0.0016
331 PNEUMOCYSTIS JIROVECII PNEUMONIA 16 0.0016
332 LARGE INTESTINE POLYP 11 0.0016
333 PRODUCT USE COMPLAINT 25 0.0016
334 ADVERSE REACTION 21 0.0016
335 POLLAKIURIA 66 0.0016
336 APATHY 23 0.0016
337 APHONIA 22 0.0016
338 HYPERTHERMIA 12 0.0016
339 PARANOIA 27 0.0016
340 HYPOPHAGIA 40 0.0016
341 BLOOD CREATINE PHOSPHOKINASE INCREASED 45 0.0016
342 SEROTONIN SYNDROME 30 0.0016
343 ANXIETY 444 0.0016
344 TARDIVE DYSKINESIA 44 0.0016
345 HELICOBACTER INFECTION 16 0.0016
346 ANAL INCONTINENCE 14 0.0016
347 CARDIOMEGALY 19 0.0015
348 HYPERPROLACTINAEMIA 10 0.0015
349 HYPERTRIGLYCERIDAEMIA 9 0.0015
350 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 276 0.0015
351 IMMUNE THROMBOCYTOPENIA 7 0.0015
352 ILEUS 19 0.0015
353 HYPOGAMMAGLOBULINAEMIA 10 0.0015
354 JOINT DISLOCATION 16 0.0015
355 PRODUCT DISTRIBUTION ISSUE 14 0.0015
356 BLOOD PRESSURE DECREASED 100 0.0015
357 SYMPTOM RECURRENCE 9 0.0015
358 DEPRESSED MOOD 79 0.0015
359 THERAPEUTIC RESPONSE UNEXPECTED 67 0.0015
360 ORTHOSTATIC HYPOTENSION 26 0.0015
361 DERMATITIS CONTACT 17 0.0015
362 CEREBRAL DISORDER 11 0.0015
363 INGUINAL HERNIA 9 0.0015
364 COMPLETED SUICIDE 123 0.0015
365 MUSCLE TWITCHING 34 0.0015
366 THIRST 26 0.0015
367 DRUG INTERACTION 229 0.0014
368 TINNITUS 66 0.0014
369 INTERMENSTRUAL BLEEDING 8 0.0014
370 MYOCLONUS 17 0.0014
371 CONTRAINDICATED PRODUCT ADMINISTERED 43 0.0014
372 ORGANISING PNEUMONIA 7 0.0014
373 SEIZURE 163 0.0014
374 FACIAL PARALYSIS 12 0.0014
375 CRYING 51 0.0014
376 OCCUPATIONAL EXPOSURE TO PRODUCT 9 0.0014
377 SALIVARY HYPERSECRETION 14 0.0014
378 HEPATIC ENCEPHALOPATHY 13 0.0014
379 INTENTIONAL SELF-INJURY 28 0.0014
380 PRODUCT DOSE OMISSION 90 0.0014
381 BRADYPHRENIA 9 0.0014
382 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 66 0.0014
383 EPILEPSY 42 0.0014
384 PRODUCT USE ISSUE 257 0.0014
385 PRODUCT COLOUR ISSUE 7 0.0014
386 APHASIA 41 0.0014
387 SHOCK HAEMORRHAGIC 11 0.0013
388 ADVERSE DRUG REACTION 121 0.0013
389 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
390 HYPOKALAEMIA 62 0.0013
391 COLON CANCER 20 0.0013
392 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
393 COLITIS ISCHAEMIC 9 0.0013
394 MUSCULAR WEAKNESS 151 0.0013
395 PRODUCT LABEL ISSUE 9 0.0013
396 TREMOR 220 0.0013
397 DEPRESSION 300 0.0013
398 DISORIENTATION 52 0.0013
399 PULMONARY ARTERIAL HYPERTENSION 19 0.0013
400 PERIPHERAL COLDNESS 18 0.0013
401 ANAL ABSCESS 7 0.0013
402 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
403 HEADACHE 813 0.0013
404 LARGE INTESTINE PERFORATION 9 0.0013
405 DYSPHAGIA 123 0.0013
406 BEHAVIOUR DISORDER 7 0.0013
407 SKIN LACERATION 14 0.0013
408 CARDIAC FAILURE 103 0.0013
409 NERVOUSNESS 67 0.0013
410 MULTIPLE ALLERGIES 10 0.0013
411 AFFECTIVE DISORDER 10 0.0013
412 PROSTATIC DISORDER 7 0.0013
413 DRUG SCREEN POSITIVE 10 0.0013
414 OVERDOSE 272 0.0013
415 GINGIVAL PAIN 10 0.0013
416 NEUTROPHIL COUNT DECREASED 51 0.0013
417 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
418 FALL 416 0.0012
419 MIGRAINE 119 0.0012
420 SENSORY DISTURBANCE 20 0.0012
421 LYMPHOCYTE COUNT DECREASED 22 0.0012
422 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
423 TONGUE DISORDER 9 0.0012
424 ROAD TRAFFIC ACCIDENT 52 0.0012
425 INSURANCE ISSUE 19 0.0012
426 SENSORY LOSS 10 0.0012
427 MULTIPLE ORGAN DYSFUNCTION SYNDROME 35 0.0012
428 INCONTINENCE 13 0.0012
429 HYPOGLYCAEMIA 59 0.0012
430 LIP DRY 11 0.0012
431 MOOD ALTERED 33 0.0012
432 METABOLIC DISORDER 7 0.0012
433 PNEUMOTHORAX 19 0.0012
434 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
435 COMA 57 0.0012
436 CHOLECYSTITIS 14 0.0012
437 LOSS OF CONSCIOUSNESS 150 0.0012
438 MUSCLE RIGIDITY 14 0.0012
439 HEPATITIS CHOLESTATIC 7 0.0012
440 RESPIRATION ABNORMAL 8 0.0012
441 DROOLING 8 0.0012
442 INCREASED APPETITE 22 0.0012
443 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
444 URINE OUTPUT DECREASED 10 0.0011
445 AFFECT LABILITY 11 0.0011
446 MEMORY IMPAIRMENT 157 0.0011
447 ELECTROCARDIOGRAM QT PROLONGED 41 0.0011
448 AGGRESSION 57 0.0011
449 PULMONARY CONGESTION 15 0.0011
450 HYPONATRAEMIA 64 0.0011
451 COLD SWEAT 20 0.0011
452 HAEMORRHOIDS 22 0.0011
453 SPEECH DISORDER 59 0.0011
454 ELECTROLYTE IMBALANCE 13 0.0011
455 THERAPY CHANGE 11 0.0011
456 BLEPHAROSPASM 7 0.0011
457 INTENTIONAL PRODUCT MISUSE 97 0.0011
458 HYPOTHYROIDISM 35 0.0011
459 MAJOR DEPRESSION 8 0.0011
460 CHOLESTASIS 21 0.0011
461 CONFUSIONAL STATE 175 0.0011
462 SUBARACHNOID HAEMORRHAGE 11 0.0011
463 LETHARGY 62 0.0011
464 MALNUTRITION 12 0.0011
465 FIBROMYALGIA 26 0.0011
466 NO THERAPEUTIC RESPONSE 13 0.0011
467 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
468 DIZZINESS 531 0.0011
469 ARTERIOSCLEROSIS 10 0.0011
470 VENTRICULAR EXTRASYSTOLES 11 0.0011
471 MENTAL DISORDER 46 0.0011
472 BRADYCARDIA 56 0.0011
473 DECREASED APPETITE 245 0.0011
474 HYPERCALCAEMIA 13 0.0011
475 VITAMIN D DECREASED 9 0.0011
476 MICTURITION URGENCY 12 0.0010
477 SHOCK 24 0.0010
478 SCRATCH 11 0.0010
479 THERAPEUTIC RESPONSE DECREASED 63 0.0010
480 METASTASES TO LYMPH NODES 7 0.0010
481 HYPERCHOLESTEROLAEMIA 10 0.0010
482 GENERALISED TONIC-CLONIC SEIZURE 17 0.0010
483 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 73 0.0010
484 TUMOUR LYSIS SYNDROME 9 0.0010
485 CYTOMEGALOVIRUS INFECTION 17 0.0010
486 RIB FRACTURE 21 0.0010
487 TORSADE DE POINTES 8 0.0010
488 AUTOIMMUNE HEPATITIS 7 0.0010
489 GASTROINTESTINAL INFECTION 9 0.0010
490 FRACTURE 19 0.0010
491 PRODUCT DOSE OMISSION ISSUE 295 0.0010
492 INJECTION SITE INDURATION 13 0.0010
493 LIMB DISCOMFORT 31 0.0010
494 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
495 HYPOAESTHESIA ORAL 15 0.0010
496 RHINITIS 8 0.0010
497 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
498 NEURALGIA 24 0.0010
499 COGNITIVE DISORDER 46 0.0010
500 INTENTIONAL DOSE OMISSION 28 0.0010
501 IRON DEFICIENCY ANAEMIA 9 0.0010
502 DYSPHONIA 57 0.0010
503 DEVICE RELATED INFECTION 15 0.0010
504 TEMPERATURE INTOLERANCE 10 0.0010
505 FAECES SOFT 7 0.0010
506 C-REACTIVE PROTEIN INCREASED 35 0.0010
507 SWOLLEN TONGUE 30 0.0010
508 FOOT FRACTURE 18 0.0009
509 PSYCHOTIC DISORDER 28 0.0009
510 HYPOPHOSPHATAEMIA 7 0.0009
511 URINARY INCONTINENCE 28 0.0009
512 STEVENS-JOHNSON SYNDROME 21 0.0009
513 DRUG PRESCRIBING ERROR 18 0.0009
514 TASTE DISORDER 19 0.0009
515 ACCIDENTAL OVERDOSE 34 0.0009
516 ATAXIA 11 0.0009
517 PLEURAL EFFUSION 56 0.0009
518 DEHYDRATION 122 0.0009
519 DISABILITY 18 0.0009
520 DRUG EFFECT DECREASED 49 0.0009
521 PURPURA 8 0.0009
522 ASPARTATE AMINOTRANSFERASE INCREASED 48 0.0009
523 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
524 PELVIC FRACTURE 7 0.0009
525 CYTOPENIA 11 0.0009
526 FEELING COLD 25 0.0009
527 DYSURIA 33 0.0009
528 JAUNDICE 24 0.0009
529 BALANCE DISORDER 77 0.0009
530 GASTROENTERITIS 13 0.0009
531 OCULAR DISCOMFORT 10 0.0009
532 GENERALISED OEDEMA 11 0.0009
533 GASTROENTERITIS VIRAL 16 0.0009
534 TOOTH EXTRACTION 11 0.0009
535 BLOOD ALBUMIN DECREASED 7 0.0009
536 MALAISE 386 0.0009
537 HYPERGLYCAEMIA 32 0.0009
538 EAR DISCOMFORT 9 0.0009
539 PULMONARY MASS 13 0.0009
540 ANGINA PECTORIS 25 0.0009
541 MYOCARDITIS 10 0.0009
542 DISCOMFORT 53 0.0009
543 CONDITION AGGRAVATED 264 0.0009
544 METASTASES TO LUNG 10 0.0009
545 HUNGER 12 0.0009
546 HYPERKALAEMIA 30 0.0009
547 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 22 0.0009
548 POLYURIA 7 0.0009
549 HYPERHIDROSIS 109 0.0008
550 SPINAL DISORDER 8 0.0008
551 BACTERAEMIA 10 0.0008
552 EOSINOPHIL COUNT INCREASED 7 0.0008
553 PRODUCT PRESCRIBING ERROR 20 0.0008
554 FEMUR FRACTURE 26 0.0008
555 DECREASED ACTIVITY 9 0.0008
556 PRURITUS GENERALISED 18 0.0008
557 PARAESTHESIA ORAL 12 0.0008
558 INFUSION SITE ERYTHEMA 7 0.0008
559 PLATELET COUNT DECREASED 88 0.0008
560 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
561 DRUG RESISTANCE 21 0.0008
562 GAIT DISTURBANCE 156 0.0008
563 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
564 ACUTE KIDNEY INJURY 124 0.0008
565 LIMB INJURY 22 0.0008
566 LIGAMENT SPRAIN 8 0.0008
567 HYPOAESTHESIA 121 0.0008
568 ILLNESS 83 0.0008
569 TRANSIENT ISCHAEMIC ATTACK 27 0.0008
570 TOXIC SKIN ERUPTION 8 0.0008
571 ECONOMIC PROBLEM 12 0.0008
572 HYPOTHERMIA 8 0.0008
573 GASTRIC ULCER 15 0.0008
574 PYREXIA 273 0.0008
575 DYSSTASIA 23 0.0008
576 HEART RATE INCREASED 78 0.0008
577 DRY THROAT 8 0.0008
578 DRUG DOSE OMISSION 130 0.0008
579 TREATMENT NONCOMPLIANCE 43 0.0008
580 MOOD SWINGS 25 0.0008
581 ALANINE AMINOTRANSFERASE INCREASED 48 0.0008
582 HAEMOLYTIC ANAEMIA 7 0.0008
583 MYOSITIS 7 0.0008
584 PHARYNGEAL OEDEMA 12 0.0008
585 FATIGUE 607 0.0008
586 CONSTIPATION 170 0.0008
587 ERECTILE DYSFUNCTION 20 0.0008
588 OROPHARYNGEAL DISCOMFORT 7 0.0008
589 FACE OEDEMA 13 0.0008
590 DIPLOPIA 20 0.0008
591 EYE DISCHARGE 8 0.0008
592 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
593 BLOOD POTASSIUM DECREASED 23 0.0008
594 HAND DEFORMITY 10 0.0008
595 DRY EYE 38 0.0008
596 BEDRIDDEN 10 0.0008
597 SEPTIC SHOCK 33 0.0008
598 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
599 VERTIGO 46 0.0008
600 CELLULITIS 38 0.0008
601 TOXICITY TO VARIOUS AGENTS 127 0.0008
602 DRUG ADMINISTRATION ERROR 23 0.0007
603 NAUSEA 592 0.0007
604 PRODUCT USE IN UNAPPROVED INDICATION 185 0.0007
605 INTESTINAL OBSTRUCTION 28 0.0007
606 CHEST DISCOMFORT 76 0.0007
607 PHARYNGITIS STREPTOCOCCAL 8 0.0007
608 PRODUCT TASTE ABNORMAL 10 0.0007
609 PROTEINURIA 14 0.0007
610 PRODUCT DISPENSING ERROR 16 0.0007
611 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
612 ABDOMINAL DISCOMFORT 123 0.0007
613 SPINAL OPERATION 9 0.0007
614 RENAL DISORDER 34 0.0007
615 PRODUCT QUALITY ISSUE 99 0.0007
616 CEREBRAL HAEMORRHAGE 26 0.0007
617 ILL-DEFINED DISORDER 44 0.0007
618 THERAPEUTIC RESPONSE SHORTENED 24 0.0007
619 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
620 LIP SWELLING 24 0.0007
621 PNEUMONIA 233 0.0007
622 ORAL DISCOMFORT 10 0.0007
623 GAIT INABILITY 24 0.0007
624 CHOKING 14 0.0007
625 CARPAL TUNNEL SYNDROME 10 0.0007
626 BLOOD PRESSURE FLUCTUATION 17 0.0007
627 DIABETIC KETOACIDOSIS 17 0.0007
628 HEPATIC CYTOLYSIS 9 0.0007
629 CIRCULATORY COLLAPSE 12 0.0007
630 IMPAIRED WORK ABILITY 15 0.0007
631 HYPERTENSION 148 0.0007
632 HEPATIC STEATOSIS 13 0.0007
633 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
634 MUSCULOSKELETAL DISCOMFORT 12 0.0007
635 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
636 UPPER RESPIRATORY TRACT INFECTION 32 0.0007
637 STOMATITIS 42 0.0007
638 FAECES DISCOLOURED 15 0.0007
639 MYELODYSPLASTIC SYNDROME 10 0.0007
640 EYE PAIN 39 0.0007
641 INTENTIONAL PRODUCT USE ISSUE 60 0.0007
642 EOSINOPHILIA 12 0.0007
643 SEXUAL DYSFUNCTION 8 0.0007
644 BLOOD PRESSURE INCREASED 104 0.0007
645 MUSCLE TIGHTNESS 11 0.0007
646 COVID-19 119 0.0007
647 MYALGIA 115 0.0007
648 SKIN HAEMORRHAGE 10 0.0007
649 DYSTONIA 13 0.0007
650 WRIST FRACTURE 8 0.0007
651 SINUS CONGESTION 9 0.0007
652 BONE LOSS 10 0.0007
653 MALIGNANT NEOPLASM PROGRESSION 68 0.0007
654 FEBRILE NEUTROPENIA 44 0.0007
655 OSTEOMYELITIS 12 0.0007
656 WEIGHT INCREASED 148 0.0007
657 WRONG TECHNIQUE IN DRUG USAGE PROCESS 24 0.0007
658 ANAPHYLACTIC SHOCK 17 0.0007
659 OXYGEN SATURATION DECREASED 37 0.0007
660 NEPHROLITHIASIS 30 0.0007
661 SMALL INTESTINAL OBSTRUCTION 8 0.0006
662 HEMIPARESIS 11 0.0006
663 PERICARDIAL EFFUSION 15 0.0006
664 HAEMOPTYSIS 18 0.0006
665 COORDINATION ABNORMAL 9 0.0006
666 PHARYNGITIS 8 0.0006
667 ANAEMIA 123 0.0006
668 NECK PAIN 36 0.0006
669 URINARY TRACT INFECTION 109 0.0006
670 PHOTOPHOBIA 12 0.0006
671 STAPHYLOCOCCAL INFECTION 21 0.0006
672 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
673 DENTAL CARIES 7 0.0006
674 CHRONIC KIDNEY DISEASE 48 0.0006
675 RESPIRATORY FAILURE 46 0.0006
676 PERITONITIS 13 0.0006
677 SCIATICA 10 0.0006
678 PALLOR 17 0.0006
679 GLAUCOMA 12 0.0006
680 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
681 CARDIO-RESPIRATORY ARREST 26 0.0006
682 HYPERTHYROIDISM 9 0.0006
683 LYMPHADENOPATHY 22 0.0006
684 HERNIA 12 0.0006
685 ERUCTATION 12 0.0006
686 WITHDRAWAL SYNDROME 26 0.0006
687 HIATUS HERNIA 8 0.0006
688 RESPIRATORY ARREST 17 0.0006
689 EMOTIONAL DISORDER 19 0.0006
690 ORAL HERPES 12 0.0006
691 SURGERY 36 0.0006
692 INTERNAL HAEMORRHAGE 7 0.0006
693 ARRHYTHMIA 29 0.0006
694 KIDNEY INFECTION 12 0.0006
695 CARDIOMYOPATHY 9 0.0006
696 JOINT INJURY 13 0.0006
697 OEDEMA 33 0.0006
698 TOOTHACHE 11 0.0006
699 LIVER FUNCTION TEST INCREASED 13 0.0006
700 MUSCLE SPASMS 111 0.0006
701 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
702 PARAESTHESIA 95 0.0006
703 DIABETES MELLITUS 46 0.0006
704 EXPIRED PRODUCT ADMINISTERED 20 0.0006
705 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
706 MOBILITY DECREASED 43 0.0006
707 THROAT TIGHTNESS 16 0.0006
708 MELAENA 13 0.0006
709 BACTERIAL INFECTION 11 0.0006
710 VOMITING 277 0.0006
711 PNEUMONITIS 16 0.0006
712 ACCIDENT 7 0.0006
713 DYSPNOEA EXERTIONAL 22 0.0006
714 OFF LABEL USE 511 0.0006
715 OSTEOPOROSIS 24 0.0006
716 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
717 MUSCULOSKELETAL STIFFNESS 51 0.0006
718 RESPIRATORY TRACT INFECTION 15 0.0006
719 ATRIAL FIBRILLATION 56 0.0006
720 HERPES ZOSTER 33 0.0006
721 DIARRHOEA 370 0.0006
722 PANCYTOPENIA 32 0.0006
723 CHILLS 67 0.0006
724 GASTROOESOPHAGEAL REFLUX DISEASE 46 0.0006
725 LUNG DISORDER 28 0.0006
726 LIVER INJURY 14 0.0006
727 SYNCOPE 57 0.0006
728 METASTASES TO LIVER 10 0.0006
729 ANAPHYLACTIC REACTION 31 0.0006
730 HOT FLUSH 42 0.0006
731 SEPSIS 62 0.0006
732 SINUS DISORDER 11 0.0006
733 DYSGEUSIA 41 0.0006
734 CHOLELITHIASIS 18 0.0005
735 ASCITES 16 0.0005
736 MULTIPLE SCLEROSIS 26 0.0005
737 HEART RATE DECREASED 19 0.0005
738 DRUG WITHDRAWAL SYNDROME NEONATAL 8 0.0005
739 CONTUSION 52 0.0005
740 BLOOD UREA INCREASED 9 0.0005
741 NEUROPATHY PERIPHERAL 51 0.0005
742 PANCREATITIS ACUTE 12 0.0005
743 DYSPNOEA 302 0.0005
744 INCORRECT PRODUCT STORAGE 7 0.0005
745 IMMUNE SYSTEM DISORDER 7 0.0005
746 HEPATIC FAILURE 16 0.0005
747 BLOOD SODIUM DECREASED 10 0.0005
748 ABDOMINAL PAIN UPPER 109 0.0005
749 TACHYCARDIA 47 0.0005
750 PRURITUS 203 0.0005
751 EAR INFECTION 14 0.0005
752 SCAR 9 0.0005
753 MALIGNANT MELANOMA 7 0.0005
754 ARTHRITIS 41 0.0005
755 CARDIAC ARREST 43 0.0005
756 THYROID DISORDER 8 0.0005
757 RASH 226 0.0005
758 BLOOD BILIRUBIN INCREASED 14 0.0005
759 WHITE BLOOD CELL COUNT DECREASED 56 0.0005
760 AMENORRHOEA 9 0.0005
761 MENINGIOMA 8 0.0005
762 HYPOXIA 18 0.0005
763 LUNG NEOPLASM MALIGNANT 21 0.0005
764 VISION BLURRED 70 0.0005
765 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
766 ASTHENIA 191 0.0005
767 BACK PAIN 118 0.0005
768 OBESITY 8 0.0005
769 UPPER LIMB FRACTURE 10 0.0005
770 BLOOD GLUCOSE DECREASED 24 0.0005
771 PREMATURE BABY 15 0.0005
772 DEVICE OCCLUSION 7 0.0005
773 PRODUCT PHYSICAL ISSUE 10 0.0005
774 PRODUCT ADMINISTRATION ERROR 10 0.0005
775 PAIN IN JAW 14 0.0005
776 GASTRITIS 13 0.0005
777 NASAL CONGESTION 29 0.0005
778 BACK DISORDER 8 0.0005
779 GLOSSODYNIA 11 0.0005
780 CHEST PAIN 91 0.0005
781 WEIGHT DECREASED 137 0.0005
782 HYPERSENSITIVITY 91 0.0005
783 BURNING SENSATION 34 0.0005
784 VENTRICULAR TACHYCARDIA 8 0.0005
785 PHOTOSENSITIVITY REACTION 8 0.0005
786 AGRANULOCYTOSIS 9 0.0005
787 HYPOKINESIA 7 0.0005
788 FUNGAL INFECTION 16 0.0005
789 SKIN DISORDER 16 0.0005
790 ECZEMA 25 0.0005
791 DYSPEPSIA 47 0.0005
792 FLATULENCE 27 0.0005
793 VISUAL IMPAIRMENT 59 0.0005
794 SWELLING FACE 31 0.0005
795 MOUTH ULCERATION 10 0.0005
796 RESPIRATORY DISTRESS 13 0.0005
797 DIVERTICULITIS 13 0.0005
798 POST PROCEDURAL COMPLICATION 9 0.0005
799 THROAT IRRITATION 21 0.0005
800 RESPIRATORY DISORDER 14 0.0005
801 OEDEMA PERIPHERAL 57 0.0005
802 THERAPY CESSATION 24 0.0005
803 MULTIPLE SCLEROSIS RELAPSE 32 0.0005
804 WOUND 13 0.0005
805 COUGH 130 0.0005
806 LACRIMATION INCREASED 14 0.0005
807 RASH GENERALISED 12 0.0005
808 BLOOD CREATININE INCREASED 30 0.0005
809 DEAFNESS 12 0.0005
810 ANHEDONIA 12 0.0005
811 NASOPHARYNGITIS 84 0.0005
812 PAIN IN EXTREMITY 134 0.0005
813 HEPATIC ENZYME INCREASED 31 0.0005
814 EPISTAXIS 34 0.0005
815 HAEMATOCRIT DECREASED 9 0.0005
816 LYMPHOMA 7 0.0005
817 INFUSION RELATED REACTION 30 0.0005
818 ANKLE FRACTURE 7 0.0005
819 OSTEOARTHRITIS 19 0.0004
820 ENCEPHALOPATHY 11 0.0004
821 OSTEONECROSIS OF JAW 11 0.0004
822 OROPHARYNGEAL PAIN 41 0.0004
823 HEART RATE IRREGULAR 10 0.0004
824 LEUKOCYTOSIS 8 0.0004
825 END STAGE RENAL DISEASE 8 0.0004
826 GENERAL PHYSICAL HEALTH DETERIORATION 50 0.0004
827 CONJUNCTIVITIS 8 0.0004
828 ABDOMINAL DISTENSION 45 0.0004
829 INFLUENZA 48 0.0004
830 URTICARIA 72 0.0004
831 HOSPITALISATION 66 0.0004
832 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
833 KNEE ARTHROPLASTY 9 0.0004
834 HEPATIC CIRRHOSIS 8 0.0004
835 PULMONARY OEDEMA 19 0.0004
836 HYPOCALCAEMIA 8 0.0004
837 COLITIS 16 0.0004
838 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
839 MUSCULOSKELETAL DISORDER 8 0.0004
840 EYE PRURITUS 14 0.0004
841 NERVOUS SYSTEM DISORDER 13 0.0004
842 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
843 RENAL FAILURE 55 0.0004
844 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
845 BRONCHITIS 30 0.0004
846 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
847 DRUG INTOLERANCE 39 0.0004
848 SKIN LESION 11 0.0004
849 AGEUSIA 10 0.0004
850 SINUSITIS 41 0.0004
851 EYE IRRITATION 23 0.0004
852 FULL BLOOD COUNT DECREASED 8 0.0004
853 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
854 MENTAL STATUS CHANGES 11 0.0004
855 MEDICATION ERROR 22 0.0004
856 GASTROINTESTINAL HAEMORRHAGE 33 0.0004
857 HAEMATEMESIS 10 0.0004
858 BONE MARROW FAILURE 8 0.0004
859 MATERNAL EXPOSURE DURING PREGNANCY 35 0.0004
860 ISCHAEMIC STROKE 7 0.0004
861 FEELING HOT 24 0.0004
862 ABDOMINAL PAIN 91 0.0004
863 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
864 MYELOSUPPRESSION 14 0.0004
865 RHINORRHOEA 25 0.0004
866 ERYTHEMA 79 0.0004
867 PULMONARY HYPERTENSION 8 0.0004
868 UNEVALUABLE EVENT 29 0.0004
869 BONE DENSITY DECREASED 12 0.0004
870 JOINT STIFFNESS 10 0.0004
871 HAEMATURIA 13 0.0004
872 EYE SWELLING 14 0.0004
873 RETCHING 8 0.0004
874 PAIN 230 0.0004
875 HYPOTENSION 75 0.0004
876 LOCALISED INFECTION 9 0.0004
877 HYPOACUSIS 16 0.0004
878 PRESYNCOPE 9 0.0004
879 INFLAMMATION 19 0.0004
880 EXTRAPYRAMIDAL DISORDER 9 0.0004
881 VISUAL ACUITY REDUCED 12 0.0004
882 TOOTH DISORDER 8 0.0004
883 RASH MACULO-PAPULAR 8 0.0004
884 INCORRECT DOSE ADMINISTERED 82 0.0004
885 BONE PAIN 21 0.0004
886 OCULAR HYPERAEMIA 17 0.0004
887 COLITIS ULCERATIVE 16 0.0004
888 ORAL PAIN 8 0.0004
889 RASH PAPULAR 8 0.0004
890 TYPE 2 DIABETES MELLITUS 12 0.0004
891 BLISTER 20 0.0004
892 PRODUCT STORAGE ERROR 31 0.0004
893 FLUID RETENTION 18 0.0004
894 ARTHRALGIA 147 0.0004
895 INFECTION 51 0.0004
896 HAEMOGLOBIN DECREASED 36 0.0004
897 HAEMATOMA 9 0.0003
898 GASTROINTESTINAL DISORDER 31 0.0003
899 EXTRA DOSE ADMINISTERED 14 0.0003
900 HAEMATOCHEZIA 19 0.0003
901 PERIPHERAL SWELLING 53 0.0003
902 METABOLIC ACIDOSIS 11 0.0003
903 LIVER FUNCTION TEST ABNORMAL 10 0.0003
904 NEEDLE ISSUE 10 0.0003
905 ACUTE MYOCARDIAL INFARCTION 10 0.0003
906 DEEP VEIN THROMBOSIS 22 0.0003
907 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
908 WHEEZING 20 0.0003
909 THERAPY INTERRUPTED 24 0.0003
910 IMPAIRED HEALING 11 0.0003
911 VIRAL INFECTION 11 0.0003
912 IRRITABLE BOWEL SYNDROME 7 0.0003
913 FLUSHING 33 0.0003
914 PROCEDURAL PAIN 9 0.0003
915 DEVICE DISLOCATION 14 0.0003
916 BLOOD CHOLESTEROL INCREASED 15 0.0003
917 CARDIAC DISORDER 30 0.0003
918 GASTRIC DISORDER 11 0.0003
919 GASTRIC CANCER 8 0.0003
920 PULMONARY EMBOLISM 30 0.0003
921 TREATMENT FAILURE 26 0.0003
922 ASTHMA 35 0.0003
923 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
924 EYE DISORDER 10 0.0003
925 DRUG ABUSE 25 0.0003
926 EMOTIONAL DISTRESS 36 0.0003
927 RASH PRURITIC 16 0.0003
928 BLINDNESS 12 0.0003
929 MUSCULOSKELETAL PAIN 15 0.0003
930 THROMBOCYTOPENIA 32 0.0003
931 CATARACT 17 0.0003
932 RED BLOOD CELL COUNT DECREASED 8 0.0003
933 LACTIC ACIDOSIS 9 0.0003
934 ALOPECIA 54 0.0003
935 ABORTION SPONTANEOUS 11 0.0003
936 EXPOSURE DURING PREGNANCY 17 0.0003
937 RASH ERYTHEMATOUS 13 0.0003
938 RENAL INJURY 8 0.0003
939 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
940 NEUTROPENIA 36 0.0003
941 SKIN DISCOLOURATION 12 0.0003
942 FREQUENT BOWEL MOVEMENTS 7 0.0003
943 RECTAL HAEMORRHAGE 11 0.0003
944 PRODUCTIVE COUGH 12 0.0003
945 CYSTITIS 8 0.0003
946 ACNE 19 0.0003
947 HIP FRACTURE 8 0.0002
948 THROMBOSIS 20 0.0002
949 MYOCARDIAL INFARCTION 43 0.0002
950 PSORIATIC ARTHROPATHY 10 0.0002
951 INFLUENZA LIKE ILLNESS 20 0.0002
952 PANCREATIC CARCINOMA 7 0.0002
953 CARDIAC FAILURE CONGESTIVE 19 0.0002
954 DEATH 200 0.0002
955 DISEASE RECURRENCE 11 0.0002
956 CORONARY ARTERY DISEASE 7 0.0002
957 DRUG DEPENDENCE 37 0.0002
958 INJECTION SITE RASH 7 0.0002
959 SKIN EXFOLIATION 19 0.0002
960 CEREBROVASCULAR ACCIDENT 38 0.0002
961 BLOOD GLUCOSE INCREASED 42 0.0002
962 DISEASE PROGRESSION 26 0.0002
963 JOINT SWELLING 26 0.0002
964 INJURY 15 0.0002
965 NEOPLASM MALIGNANT 14 0.0002
966 PANCREATITIS 11 0.0002
967 SWELLING 19 0.0002
968 DRY SKIN 27 0.0002
969 ARTHROPATHY 11 0.0002
970 INJECTION SITE MASS 7 0.0002
971 INJECTION SITE PAIN 57 0.0002
972 HAEMORRHAGE 19 0.0002
973 LEUKOPENIA 9 0.0002
974 DERMATITIS ATOPIC 9 0.0002
975 INJECTION SITE ERYTHEMA 21 0.0002
976 PROSTATE CANCER 13 0.0002
977 INJECTION SITE REACTION 11 0.0002
978 DRUG WITHDRAWAL SYNDROME 14 0.0002
979 ANGIOEDEMA 7 0.0002
980 INJECTION SITE SWELLING 12 0.0002
981 INJECTION SITE BRUISING 12 0.0002
982 INJECTION SITE PRURITUS 10 0.0001
983 DEVICE ISSUE 13 0.0001
984 PSORIASIS 18 0.0001
985 PRODUCT SUBSTITUTION ISSUE 7 0.0001
986 RHEUMATOID ARTHRITIS 13 0.0001
987 BREAST CANCER 9 0.0001